Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A M Fraga

Showing results (51-60 of 113) with videos related to

Pageof 12
Sort By:
Acta Crystallographica. Section E, Structure Reports Online|July 17, 2012
(2E)-N'-[(E)-Benzyl-idene]-3-phenyl-prop-2-enohydrazide from synchrotron radiationSamir A Carvalho, Edson F da Silva, Carlos A M Fraga, et al.
Pharmacology, Biochemistry, and Behavior|July 29, 2009
Sedation and antinociception induced by a new pyrazolo[3,4-b]pyrrolo[3,4-d]pyridine derivative (LASSBio-873) is modulated by activation of muscarinic receptorsThaiana C F Mendes, Juliana M Raimundo, Nailton M Nascimento-Junior, et al.
Antimicrobial Agents and Chemotherapy|March 17, 2010
In vitro and in vivo activities of 1,3,4-thiadiazole-2-arylhydrazone derivatives of megazol against Trypanosoma cruziK Salomão, E M de Souza, S A Carvalho, et al.
Journal of Pharmaceutical and Biomedical Analysis|December 6, 2003
Validated HPLC method for determination of LASSBio-581, a new heterocyclic N-phenylpiperazine derivative, in rat plasmaL Tasso, G Neves, R Menegatti, et al.
Journal of Biomolecular Structure & Dynamics|August 31, 2011
Molecular modeling studies of Yersinia pestis dihydrofolate reductaseAline A Oliveira, Magdalena N Rennó, César A de Matos, et al.
Behavioural Brain Research|September 25, 2012
New insights into pharmacological profile of LASSBio-579, a multi-target N-phenylpiperazine derivative active on animal models of schizophreniaGilda Neves, Camila B Antonio, Andresa H Betti, et al.
Journal of Chromatography. A|February 13, 2003
Chiral separation of gamma-butyrolactone derivatives by gas chromatography on 2,3-di-O-methyl-6-O-tert.-butyldimethylsilyl-beta-cyclodextrinMaria da Conceição K V Ramos, Lis H P Teixeira, Francisco R de Aquino Neto, et al.
International Journal of Cardiology|August 25, 2015
In vivo effect of LASSBio-785, a lipid-lowering and anti-inflammatory agent, on cardiac Ca(2+)-ATPases from hypercholesterolemic ratsEmiliana B Marques, Nádia A V Motta, Arthur E Kummerle, et al.
Clinical and Experimental Pharmacology & Physiology|April 12, 2013
Antihyperalgesic effects of a novel muscarinic agonist (LASSBio-873) in spinal nerve ligation in ratsThaiana C F Mendes, Fernanda Antunes, Margarete M Trachez, et al.
Bioorganic & Medicinal Chemistry Letters|December 12, 2001
Design, synthesis and pharmacological evaluation of novel pyrazolo[3,4-b]thieno[2,3-d]pyridine acid derivatives: a new class of anti-inflammatory and anti-platelet agentsCarla R Cardoso, Fernanda C F de Brito, Kelli C M da Silva, et al.
Pageof 12

Showing results (51-60 of 113) with videos related to

Sort By:
Pageof 12
Acta Crystallographica. Section E, Structure Reports Online|July 17, 2012
(2E)-N'-[(E)-Benzyl-idene]-3-phenyl-prop-2-enohydrazide from synchrotron radiationSamir A Carvalho, Edson F da Silva, Carlos A M Fraga, et al.
Pharmacology, Biochemistry, and Behavior|July 29, 2009
Sedation and antinociception induced by a new pyrazolo[3,4-b]pyrrolo[3,4-d]pyridine derivative (LASSBio-873) is modulated by activation of muscarinic receptorsThaiana C F Mendes, Juliana M Raimundo, Nailton M Nascimento-Junior, et al.
Antimicrobial Agents and Chemotherapy|March 17, 2010
In vitro and in vivo activities of 1,3,4-thiadiazole-2-arylhydrazone derivatives of megazol against Trypanosoma cruziK Salomão, E M de Souza, S A Carvalho, et al.
Journal of Pharmaceutical and Biomedical Analysis|December 6, 2003
Validated HPLC method for determination of LASSBio-581, a new heterocyclic N-phenylpiperazine derivative, in rat plasmaL Tasso, G Neves, R Menegatti, et al.
Journal of Biomolecular Structure & Dynamics|August 31, 2011
Molecular modeling studies of Yersinia pestis dihydrofolate reductaseAline A Oliveira, Magdalena N Rennó, César A de Matos, et al.
Behavioural Brain Research|September 25, 2012
New insights into pharmacological profile of LASSBio-579, a multi-target N-phenylpiperazine derivative active on animal models of schizophreniaGilda Neves, Camila B Antonio, Andresa H Betti, et al.
Journal of Chromatography. A|February 13, 2003
Chiral separation of gamma-butyrolactone derivatives by gas chromatography on 2,3-di-O-methyl-6-O-tert.-butyldimethylsilyl-beta-cyclodextrinMaria da Conceição K V Ramos, Lis H P Teixeira, Francisco R de Aquino Neto, et al.
International Journal of Cardiology|August 25, 2015
In vivo effect of LASSBio-785, a lipid-lowering and anti-inflammatory agent, on cardiac Ca(2+)-ATPases from hypercholesterolemic ratsEmiliana B Marques, Nádia A V Motta, Arthur E Kummerle, et al.
Clinical and Experimental Pharmacology & Physiology|April 12, 2013
Antihyperalgesic effects of a novel muscarinic agonist (LASSBio-873) in spinal nerve ligation in ratsThaiana C F Mendes, Fernanda Antunes, Margarete M Trachez, et al.
Bioorganic & Medicinal Chemistry Letters|December 12, 2001
Design, synthesis and pharmacological evaluation of novel pyrazolo[3,4-b]thieno[2,3-d]pyridine acid derivatives: a new class of anti-inflammatory and anti-platelet agentsCarla R Cardoso, Fernanda C F de Brito, Kelli C M da Silva, et al.
Pageof 12